Pay in 4 interest-free payments of $7.26 Learn more
.webp)
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
doi: 10.1186/1472-6882-13-253 50
Andreeff M , Zhao S, Xie Z, Konopleva M, Estey E, Munsell M, Sanchez-Williams G, Kornblau S, Reed J
Tina Reddy
Engineering new peptides with desired selectivity profiles requires time-consuming and expensive cycles of design-make-test-analyse (DMTA) work
Wegovy, Zepbound, and Saxenda are currently the only GLP-1 agonists approved as weight loss drugs
Therefore, diabetic patients with acromegaly could be treated with SGLT-2i, albeit caution is required for patients with uncontrolled disease
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
